On Wednesday, the market took a tumble with the Dow Jones losing over 1, 100 points. Surprisingly, this happened after the Federal Reserve announced plans to cut interest rates twice more in 2025. The S&P 500 and Russell 2000 also suffered significant losses, falling below important thresholds. Trea
Mary Ann Bartels, the chief investment strategist at Sanctuary Wealth, has a compelling vision for the S&P 500 in 2025. She predicts the broad market index could surge more than 20%, reaching between 7, 200 and 7, 400 points. This forecast is about 22% higher than the S&P 500's closing on Monday. Ba
Investors always want to boost their portfolios. One smart way to do this is by looking at forecasts for the coming year. This year, we're not focusing on the usual big names like Meta, Amazon, or Tesla. Instead, let's shine a light on seven smaller, but promising stocks. TG Therapeutics (TGTX) is
The tech industry is buzzing with excitement thanks to generative AI and expectations of lower interest rates. This has led some tech stocks to soar. But which one will climb the highest? Let's compare Apple (AAPL), Nvidia (NVDA), and Alibaba (BABA) to see which one analysts think has the most upsid
Asian stock markets shot up on Tuesday, following a record-breaking finish on Wall Street led by tech stocks. The S&P 500 hit an all-time high for the 54th time this year, while the Dow Jones dipped slightly. Some experts think Japan's stocks might benefit from President Trump's latest tariff threat
HSBC is optimistic about China's economic turnaround, thanks to recent government measures. Two stocks they're eyeing for 2025 are KE Holdings and Hongfa Technology. KE Holdings, a real estate player, might see a big boost if the property market rebounds. HSBC thinks its stocks could jump by over 70
Shares in dental supply company Henry Schein shot up on Monday, with investors anticipating changes in public health policies under a potential new administration. The move was sparked by the appointment of Robert F. Kennedy Jr. as a contender for the Health and Human Services role. Kennedy's previo
The U. S. healthcare sector has been through a rough patch since the presidential election, with stocks like Danaher and Eli Lilly taking a hit. This uncertainty stems from President-elect Trump's choice for the Secretary of Health and Human Services, Robert F. Kennedy Jr. , known for his skepticism
President Donald Trump is set to reenter the White House, and his tough talk on China is expected to shake things up for companies doing business there. Stocks like Nvidia and AMD, which sell chips to China, might face volatility. But the key question is: How much will this talk impact their busines
When President-elect Donald Trump chose Robert F. Kennedy Jr. to lead the Department of Health and Human Services, health stocks took a dive. Kennedy is known for his skepticism about vaccines, which worried investors. Companies making vaccines, like France's Sanofi and London-listed GSK, saw their
